Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer cell selective replication refers to the ability of certain therapeutic agents—most notably, engineered viruses or small molecules—to preferentially replicate within and kill cancer cells while sparing normal, healthy cells. This selectivity is often achieved by exploiting unique molecular defects or stress responses present in cancer cells but absent in normal tissue.
Exploits oncogenic signaling-induced vulnerabilities: high RS; defective checkpoints; altered metabolism
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer Cell (Selective Replication).